The group of Bioengineering, Cell therapy and Surgery in Congenital Malformations has been peformimg research focused in the research lines of congenital malformations, sucha as spina bifida and congenital diaphragmatic hernia, as well as in musculoskeletal and osteoarticular pathologies. The group has received national and international funding for the development of research activities and different studies has been published in national and international journals.
Bioengineering, Cell therapy and Surgery in Congenital Malformations
eCOREs
- Global Health
- Woman & Child Health & Rare Diseases
- Brain & Mind and Behaviour
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
Team
Group Leader
Manuel López Paredes
Principal Investigator (PI)
Carles Giné Prades, Francisco Soldado Carrera, Mario Marotta Baleriola, Héctor Boix Alonso
Researchers
José Andrés Molino Gahete, Gloria Fatou Royo Gomes, José Luis Peiró Ibáñez, Josep Maria de Bergua Domingo, Marino Asensio Llorente, Jorge Knörr Giménez
PhD Students
Laura Vidal Fornells, Ingrid Vila Fernández
Lab Technicians
Anabel Sacristán Ruiz, Pamela Dominguez Baez, Laura Lozano Marcó
Publications
17
Publications
17.6
%Q1
44
Impact Factor
2.60
Average Impact Factor
Molino, Jose Andres, Hidalgo, Ernest, Quintero, Jesus, Coma, Ana, Ortega, Juan, Juamperez, Javier, Mercadal-Hally, Maria, Riera, Lluis, Riaza, Lucia, Bilbao, Itxarone et al.
Delayed sequential abdominal wall closure in pediatric liver transplantation to overcome “large for size” scenarios.
Pediatr Transplant. 2022 Feb;26(1):e14132.
DOI: doi: 10.1111/petr.14132.
IF: 1.502
Gander, Romy, Asensio, Marino, Royo, Gloria Fatou, Lopez, Manuel et al.
Pediatric laparoscopic mitrofanoff procedure- preliminary results of a simplified technique.
J Pediatr Urol. 2022 Apr;18(2):112.e1-112.e7.
DOI: doi: 10.1016/j.jpurol.2021.12.018. Epub 2022 Jan 7.
IF: 1.83
Guillen, G, Hladun, R, Martos, M, Cano, P, Molino, J A, Lopez-Fernandez, S, Lopez, M et al.
Minimally invasive surgery for pediatric dumbbell neuroblastoma: systematic literature review and report of a single-stage neurosurgical and thoracoscopic approach.
Clin Transl Oncol. 2022 May;24(5):950-957.
DOI: doi: 10.1007/s12094-021-02724-4. Epub 2021 Oct 30.
IF: 3.405
Gander, Romy; Asensio, Marino; Andres Molino, Jose; Fatou Royo, Gloria; Lopez-Gonzalez, Mercedes; Perez, Victor; Lopez, Manuel; Ariceta, Gema et al.
Pediatric kidney retransplantation focused on surgical outcomes.
J Pediatr Urol. 2022 Jun 25. pii: S1477-5131(22)00288-1.
DOI: doi: 10.1016/j.jpurol.2022.06.019.
IF: 1.83
Knorr, Jorge; Soldado, Francisco; Violas, Philippe; Sanchez-Alvarez, Mikel; Domenech, Pedro; de Gauzy, Jerome Sales et al.
Treatment of hallux valgus in children and adolescents.
Orthop Traumatol Surg Res. 2022 Feb;108(1S):103168.
DOI: doi: 10.1016/j.otsr.2021.103168. Epub 2021 Dec 3.
IF: 2.256
Projects
nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration..
Principal Investigator: José Raul Herance Camacho
Agency: EUROPEAN COMMISSION
Funding: 1,019,687.5 €
Period: 2017-2022
Teràpia cel·lular i cirurgia en malformacions congènites
Principal Investigator: Manuel López Paredes
Agency: AGAUR
Funding: 0.01
Period: 2022-2024
ALBINO: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome
Principal Investigator: Héctor Boix Alonso
Agency: EUROPEAN COMMISSION
Funding: 0.01
Period: 2017-2022
Terapia celular para la regeneración neutral y el tratamiento del mielomeningocele en modelo experimental de feto de oveja.
Principal Investigator: Carlos Giné Prades
Agency: Instituto de Salud Carlos III
Funding: 83,490 €
Period: 2019-2023
Investigación industrial de nuevas tecnologías para el tratamiento personalizado de patologías osteoarticulares de rodilla a través de Inteligencia Artificial e implantes celularizados generados mediante bioimpresión 3D (BioprintIA)
Principal Investigator: Francisco Soldado Carrera
Agency: CENTRO PARA EL DESARROLLO TÉCNICO INDUSTRIAL (CDTI)
Funding: 153,300 €
Period: 2020-2023
Patents
METHOD TO PREDICT THE LACK OF RESPONSE TO ANTI-TNF ALPHA THERAPIES
Priority Number: PCT/EP2014/066604 (US)
Priority Date: 1/08/2014
Applicants: 66% VHIR, 33,3 % H. Clínic
RISK LOCUS FOR PSORIATIC ARTHRITIS
Priority Number: 62/151,952 (PCT)
Priority Date: 23/04/2015
Applicants: VHIR, CLINIC, IGTP
METHOD TO PREDICT RESPONSE TO TREATMENT WITH ANTI-TNF ALPHA AGENTS
Priority Number: EP14179452.9 (PCT)
Priority Date: 1/08/2014
Applicants: VHIR
Pronóstico de respuesta al tratamiento con anti-TNFalfa en pacientes de artritis reumatoide
Priority Number: P201330650 (PCT)
Priority Date: 3/05/2013
METODO IN VITRO Y KIT PARA EL PRONOSTICO O PREDICCION DE LA RESPUESTA POR PARTE DE PACIENTES CON ARTRITIS REUMATOIDE AL TRATAMIENTO CON AGENTES BLOQUEANTES DEL FACTOR TNF alfa (INFLIXIMAB)
Priority Number: P200802713 (ES)
Priority Date: 24/09/2008
Applicants: VHIR
